Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,739 INR | -1.03% | -0.64% | -9.66% |
Apr. 08 | Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals | CI |
Apr. 08 | Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.66% | 3.47B | |
+24.17% | 562B | |
-6.34% | 358B | |
+18.78% | 322B | |
+7.52% | 297B | |
+13.42% | 219B | |
+6.06% | 199B | |
-10.35% | 196B | |
-11.20% | 149B | |
-6.82% | 146B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Jefferies Downgrades Gland Pharma to Hold From Buy, Adjusts Price Target to 2,241 Indian Rupees From 2,843 Rupees